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Pitx2, a homeodomain transcription factor, is essential for normal development of the pituitary gland, craniofacial region, eyes, heart,
abdominal viscera, and limbs. Complete loss of Pitx2 in mice (Pitx2/) results in embryonic lethality by approximately e15 due to cardiac
defects, whereas embryos with partial loss of function (Pitx2neo/ or Pitx2neo/neo) survive until later in development (e17–e19). Pitx2 is
expressed in discrete populations of postmitotic neurons in the mouse brain, but its role in mammalian central nervous system (CNS)
development is not known. We undertook an analysis of Pitx2-deficient embryos to determine whether loss of Pitx2 affects CNS
development. The CNS is normal in hypomorphic e16.5 Pitx2neo/ and e18.5 Pitx2neo/neo embryos, with no evidence of midline or other
defects. Midgestation (e10.5) Pitx2/ embryos have normally formed neural tube structures and cerebral vesicles, whereas older (e14.5)
Pitx2/ embryos exhibit loss of gene expression and axonal projections in the subthalamic nucleus (a group of cells in the ventrolateral
thalamus) and in the developing superior colliculus of dorsal midbrain. Our results suggest a role for Pitx2 in regulating regionally specific
terminal neuronal differentiation in the developing ventrolateral thalamus and midbrain.
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Introduction respectively) because their cardiac defects are less severePitx2 is a paired-like homeodomain transcription factor
essential for normal development of multiple organs, includ-
ing the pituitary, heart, and eyes (Gage et al., 1999; Kitamura
et al., 1999; Lin et al., 1999; Liu et al., 2001). Mice with
complete loss of Pitx2 function die in midgestation (approx-
imately e15) due to cardiac and abdominal defects, whereas
mice with reduced Pitx2 function (Pitx2neo/ or Pitx2neo/neo)
survive until late in gestation (approximately e17 and e19,0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.10.035
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E-mail address: donnamm@umich.edu (D.M. Martin).(Gage et al., 1999). Humans heterozygous for PITX2 muta-
tions exhibit ocular, tooth, umbilical, and occasional heart
anomalies characteristic of Rieger syndrome, an autosomal
dominant multiple congenital anomaly syndrome (Semina et
al., 1996).
Human patients with Rieger syndrome can have psy-
chomotor retardation, hydrocephalus, or acrocallosal
defects including complete agenesis of the corpus callosum
(Kamnasaran et al., 2003; Kulharya et al., 1995; Makita et
al., 1995; Schinzel et al., 1997), suggesting that Pitx2
deficiency may contribute to central nervous system (CNS)
dysfunction in humans (De Hauwere et al., 1973; Moog et
al., 1998). In mouse, Pitx2 is expressed in postmitotic
neurons of the midgestation CNS, including GABAergic
neurons of future thalamus and midbrain, and neurons of
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of Pitx2 expression in the developing mouse CNS supports
the prosomere theory (Martin et al., 2002; Mucchielli et
al., 1996), in which transversal boundaries divide the
forebrain into functional units that exhibit distinct patterns
of morphology, gene expression, cell differentiation, and
cellular behavior (Figdor and Stern, 1993; Puelles and
Rubenstein, 1993). In the postnatal mouse and rat CNS,
Pitx2 localizes to the subthalamic nucleus, red nucleus,
reticular nucleus, superior colliculus, and other tegmental
areas (Asbreuk et al., 2002; Kitamura et al., 1997; Martin
et al., 2002; Mucchielli et al., 1996; Smidt et al., 1997).
Despite the evidence of Pitx2 expression in developing and
mature CNS, and the reported patients with CNS defects,
there are no reported analyses of CNS development in Pitx2-
deficient mice. Here we report our analysis of CNS devel-
opment in an allelic series of mice with varying degrees of
Pitx2 deficiency, ranging from partial loss of function
(Pitx2neo/neo) to complete loss of function (Pitx2/)
(Gage et al., 1999).
We identified a requirement of Pitx2 for normal devel-
opment of the ventrolateral thalamus and midbrain. Loss of
Pitx2 disrupts neuronal differentiation and axonal outgrowth
in the region of the ventrolateral thalamic neuroepithelium
destined to become subthalamic nucleus, and in the devel-
oping superior colliculus of dorsal midbrain. The subthala-
mic nucleus, striatum, globus pallidus, and substantia nigra
comprise an embryologically heterogeneous nuclear com-
plex classified as the mammalian basal ganglia nuclei (Albin
et al., 1989). The subthalamic nucleus is the only glutama-
tergic basal ganglia nucleus; all others contain dopaminergic
or GABAergic neurons. Increased activity of the subthala-
mic nucleus is observed in late stages of Parkinson’s
disease, and subthalamic nucleus may be involved in
behavioral disorders such as obsessive–compulsive disorder
(Guridi and Obeso, 2001; Mallet et al., 2002). Degeneration
of dopaminergic neurons in the substantia nigra was recent-
ly identified in mice with loss of Pitx3, a Pitx2-related gene
(Hwang et al., 2003; Nunes et al., 2003; Van Den Munckhof
et al., 2003). Our results showing disrupted subthalamic
nucleus development raise the possibility of a functional
transcription factor network in basal ganglia that may have
implications for the pathogenesis of Parkinson’s disease and
other movement disorders. Our studies offer a potential
experimental paradigm for exploring the cell-specific
requirements of Pitx2 in brain development and for genet-
ically dissecting basal ganglia pathways to assess their
contributions to disease phenotypes.Materials and methods
Mice
Pitx2 and Pitx2neo insertion alleles (Gage et al., 1999)
were derived from R1 embryonic stem cells and bred andmaintained in our mouse colony on a C57BL/6J back-
ground, at backcross generations N4-7. All procedures
involving mice were approved by The University of
Michigan Committee on the Use and Care of Animals
(UCUCA).
Embryo preparation, genotyping, and histology
Timed pregnancies between various combinations of
Pitx2+/ and Pitx2+/neo mice were established, with the
morning of vaginal plug identification designated as e0.5.
Following cervical dislocation and hysterectomy, embryos
at various time (e10.5–e18.5) were dissected free from the
uterus in 0.1 M PBS, pH 7.2. Yolk and amniotic sacs or
caudal aspects of each embryo were processed for genotyp-
ing as previously described (Gage et al., 1999). Embryos
were prepared for immunohistochemistry, in situ hybridiza-
tion, or TUNEL assays as previously described (Martin et
al., 2002; Raetzman et al., 2002). For histology, paraffin-
embedded sections were deparaffinized in xylene, rehy-
drated through an ethanol series, incubated 1 min in 1%
cresyl violet solution (ICN Biochemicals, Aurora, OH)
containing 0.2% glacial acetic acid (Fisher Scientific, Fair
Lawn, NJ), dehydrated and mounted in a 1:1 mixture of
Permount (Fisher) and xylene, and analyzed using bright-
field microscopy.
Scanning electron microscopy
Embryos were fixed in 2% glutaraldehyde (EM grade,
Sigma, St. Louis, MO) in 0.15 M cacodylate buffer, pH
7.2, for 2 h at 4jC. Embryos were rinsed in phosphate
buffer, pH 7.4, then bisected along the midline and
processed using the osmium thiocarbohydrazide (OTOTO)
method (Osborne and Comis, 1991), dehydrated, critical
point dried, and mounted, as described (Kawamoto et al.,
2003). Tissues were examined using a Philips XL30
Field-Emission Gun scanning electron microscope (FEI,
Hillsboro, OR).
In situ hybridization
Sections were processed for in situ hybridization essen-
tially, as previously described, using a 690-bp DraII/HindIII
Pitx2a cDNA fragment corresponding to 410 bp of protein
coding sequence and 280 bp of 3VUTR in exon 5 (Martin et
al., 2002). This probe is predicted to detect all three Pitx2
isoforms (Pitx2a, Pitx2b, Pitx2c) based on their common 3V
sequences. The substance P probe encoded a HindIII/EcoRI
498-bp fragment of rat cDNA sequence (nucleotides 23–
523, Genbank accession number, NM_012666), provided
by R. Thompson. The rat enkephalin probe was provided by
A. Seasholtz. Gad1 cDNA probe was used as previously
described (Maddox and Condie, 2001; Martin et al., 2002).
Sense control sections for all in situ probes revealed no
specific hybridization.
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PITX2 immunolabeling was performed using a polyclonal
rabbit anti-PITX2 antibody, provided by Tord Hjalt (Hjalt et
al., 2000), as previously described (Martin et al., 2002).
Double labeling was with mouse anti-NeuN (1:100, Chem-
icon, Temecula, CA), DAPI (4V,6V-diamidino-2-phenylindole,
dihydrochloride, FluoroPurek grade, 167 ng/ml, Molecular
Probes, Eugene, OR), or rabbit anti-calretinin (1:2000,
Chemicon), then FITC-conjugated secondary antibodies
from the appropriate species. Single immunoreactions were
with rabbit anti-tyrosine hydroxylase (TH; 1:100, Pelfreez,
Rogers, AR), rabbit anti-calretinin (1:2000, Chemicon),
rabbit anti-g-aminobutyric acid (GABA;1:100, Sigma),
mouse anti-MAP2 (1:200, Chemicon), mouse anti-h tubulin
III (1:1000, Covance, Richmond, VA), mouse anti-Nestin
(1:100, Developmental Studies Hybridoma Bank, Depart-
ment of Biological Sciences, University of Iowa, Iowa City,
IA), rabbit anti-phosphohistone H3 (1:200, Upstate Biotech-
nology, Placid Way, NY), mouse R-cadherin (1:1000, pro-
vided by M. Takeichi), or rabbit anti-cyclin D2 (1:200, Santa
Cruz Biotechnology, Santa Cruz, CA). Secondary antibodies
included goat anti-rabbit TRITC, anti-rat TRITC, anti-mouse
Alexa 555 (Molecular Probes) or biotinylated secondary
antibodies conjugated with streptavidin-HRP (Vector Labo-
ratories) and diaminobenzidine (DAB) with urea/peroxide
tablets (Sigma) or biotinylated secondary antibodies conju-
gated with streptavidin-Alexa488 or streptavidin-Alexa555
(Molecular Probes). Sections were analyzed by single chan-
nel fluorescence using a Leica DMRB microscope and
processed for visualization with Adobe Photoshop (v6.0).
Cell birthdating, proliferation, and apoptosis assays
Pregnant Pitx2+/ dams (bred with Pitx2+/ males) were
injected intraperitoneally with 1 mg/ml 5-bromo-2V-deoxy-
uridine (BrdU; Sigma) in sterile water. For birthdating,
injections were performed at e10.5–13.5 and embryos
harvested at e14.5. For proliferation studies, injections were
performed 30 min before embryo harvest at e14.5. Cell
death assays were done using the TUNEL method (Onco-
gene Research Products, Boston, MA) followed by methyl
green counterstaining (Vector Laboratories).
Retrograde axonal tracing with diI
E13.5 embryos were collected in PBS and fixed by
immersion in 4% paraformaldehyde at 4jC. Brains were
isolated under a dissecting microscope and microcrystals of
1,1V-dioctadecyl-3,3,3V,3V-tetramethylindocarbocyanine per-
chlorate (DiI, Molecular Probes) inserted in the diencephal-
ic–mesencephalic junction. Experimental brains were
stored in PBS for 2 weeks at 4jC. Vibratome sections,
100 Am thick, were mounted on slides, counterstained with
bisbenzimide (Hoechst 33258, Sigma), and analyzed under
fluorescence microscopy.
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PITX2 deficiency does not alter neural tube formation or
early CNS histology
Complete absence of Pitx2 function in mice leads to
embryonic lethality by e15, and homozygous null embryos
exhibit severe cardiac defects, externalization of abdominal
viscera, pituitary hypoplasia, pulmonary isomerism, ocular
abnormalities, and craniofacial abnormalities (Gage et al.,
1999; Kitamura et al., 1999; Lin et al., 1999; Liu et al.,
2001). In our studies, the Pitx2 null allele (Pitx2null or
Pitx2) lacks exon four, resulting in a mutant mRNA that
encodes a truncated or frameshifted mutant protein with no
homeodomain (Gage et al., 1999). We detected PITX2
protein in Pitx2neo/ and Pitx2neo/neo embryos using a
polyclonal anti-PITX2 antibody (data not shown); however,
we found no PITX2 signal in Pitx2/ embryos, confirming
the absence of stable PITX2 protein.
Analysis of e10.5 Pitx2/ embryos by scanning electron
microscopy (SEM) revealed normal formation of neural tube
flexures, cerebral vesicles, prosomeres, mesencephalon, and
zona limitans intrathalamica (zli), an area of high PITX2
expression (Figs. 1A, B). These results exclude a major
histological effect of Pitx2 loss of function on development
of neural tube morphology, and suggest that Pitx2may not be
essential for initial patterning of the neural tube. To evaluate
for histological abnormalities in older embryos, we exam-
ined Pitx2+/+, Pitx2+/, and Pitx2/ e14.5 embryo litter-
mates by cresyl violet staining. We found no detectable
abnormalities in any e14.5 Pitx2/ CNS structures, includ-
ing regions of high PITX2 expression such as the zona
limitans intrathalamica, zona incerta, mammillary region,
first rhombomere, and mesencephalon or future midbrain
superior colliculus (Figs. 1C, D). We also found normal CNS
histology in e18.5 Pitx2neo/neo embryos (Figs. 1E, F) in all
regions examined, including the corpus callosum, an area
affected in humans with PITX2 loss of function (Kamna-
saran et al., 2003; Kulharya et al., 1995; Makita et al., 1995;
Schinzel et al., 1997). In mice, formation of the corpus
callosum begins at e15–e17 (Del Rio et al., 2000; Deng
and Elberger, 2001), precluding analysis of the corpus
callosum in Pitx2/ embryos since they die before e15.
PITX2 is required for neuronal development of the
mesencephalon
Pitx2 mRNA transcripts persist in both the Pitx2 and
Pitx2neo alleles, as detected by in situ hybridization using a
Pitx2 cDNA probe (Figs. 2 and 4). Transcription of the
Pitx2 locus in the Pitx2/ mutant indicates that PITX2
protein is generally not necessary for activation or mainte-
nance of Pitx2 gene expression. To determine whether the
spatial and temporal pattern of Pitx2 expression is altered in
Pitx2/ mutant embryos, and as a way to identify Pitx2-
expressing cells, we analyzed wild-type and Pitx2/ em-
Fig. 1. Gross anatomical and histological analysis of Pitx2/ mutant embryos. Scanning electron microscopy (SEM) of representative left halves of wild-type
(wt, A) and Pitx2/ (B) e10.5 embryos bisected sagittally at the midline reveals intact cerebral vesicles (cv), prosomeres (p1–p3), zona limitans intrathalamica
(zli, white lines), and mesencephalon (mes). Cresyl violet labeling of e14.5 coronal sections show normal histology of wild-type (C) and Pitx2/ (D) embryos
at the level of the future superior colliculus (SC), dorsal thalamus (DT), and ventral thalamus (VT). Cresyl violet coronal sections of e18.5 wild-type (E)
Pitx2neo/neo (F) embryos shows intact corpus callosum. Abbreviations: cf, cephalic flexure; PT, pretectum; Tel, telencephalon; Hy, hypothalamus. Scale bars are
250 Am (A, B), 500 Am (C, D), and 1 mm (E, F).
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the e14.5 mesencephalon or developing midbrain, we found
a distinct difference in the pattern of Pitx2 mRNA between
wild-type and Pitx2/ embryos, with Pitx2 mRNA dis-
placed from its normal location near the pial surface toward
the intermediate and subventricular zone of the developing
superior colliculus (Figs. 2A–F). We also observed loss of
Pitx2 gene expression in the developing midbrain of e13.5embryos, where Pitx2 mRNA failed to occupy the outer-
most differentiating region of the lateral dorsal midbrain but
was preserved in more medial locations (Figs. 2G, H). These
observations suggest that Pitx2 mutant cells may undergo a
fate switch directing them to occupy deeper layers of the
future superior colliculus. In contrast to the abnormal Pitx2
expression in the developing midbrain, we found normal
Pitx2 mRNA expression in the Pitx2/ zona limitans (Figs.
Fig. 2. Developing midbrain neurons exhibit differentiation defects with loss of PITX2. In situ hybridization for Pitx2 on wild-type (left column) and Pitx2/
embryos (right column) reveals a difference in Pitx2 mRNA expression at the level of the dorsal midbrain, visible in sagittal sections (A–D) and coronal
sections (E–H). A–F, I, and J are from e14.5 embryos; G and H are e13.5 embryos. Boxes in A and B are enlarged in C and D, respectively. Panels E and F
were photographed from sections oriented as indicated by the lines in A and B, respectively. In wild-type embryos (C, E, G), Pitx2-positive nuclei are present in
the superficial mesencephalon (bracketed areas), whereas mutant embryos express Pitx2 mRNA only in deeper layers of the neuroepithelium (bracketed areas
in D, F, H). The location and number of Pitx2-positive neurons in the zona limitans (zli) are unchanged in the Pitx2/ embryo as compared to wild-type (I– J).
Abbreviations: Aq, cerebral aqueduct; SC, superior colliculus; PT, pretectum; DT, dorsal thalamus; VT, ventral thalamus; Hy, hypothalamus; Tel,
telencephalon; Cb, cerebellum. Scale bars are 100 Am (A, B, G, H) and 50 Am (C–F, I, J).
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shown), suggesting regional specificity of Pitx2 function in
the developing brain.
Given the abnormal spatial expression of Pitx2 mRNA in
the midbrain of Pitx2/ embryos, we asked whether axonal
projections from the developing midbrain are also disrupted
by loss of PITX2. To address this, we analyzed rostral
projections of developing neurons in the developing mes-
encephalon or future superior colliculus by retrograde diI
labeling. This analysis showed fewer labeled neurons in
e13.5 Pitx2/ (n = 4) brains compared to wild-type
littermates (n = 3) (Fig. 3). This suggests that Pitx2/ cells
are compromised in their radial or tangential migrations
toward the pial surface and in their ability to develop normal
axonal projections. To determine whether Pitx2 loss of
function exerts a more global effect on midbrain neuronal
gene expression or development, we analyzed the e10.5
and e14.5 midbrain for abnormalities in markers of neuro-
nal differentiation (TUJ1 or Map2 immunoreactivity),
GABAergic neurotransmitter phenotype (Gad1 mRNA or
immunoreactivity for GABA), or mitotic cells (anti-H3),
using previously described methods (Martin et al., 2002).
We found no associated defects in expression of these
markers (data not shown), suggesting that loss of Pitx2
adversely affects mesencephalic neuronal migration and
axonal outgrowth without obviously altering the number
of cells in M phase or correct GABAergic assignment of
neurons in this region.
Loss of Pitx2 function disrupts neuronal development in the
ventrolateral thalamus
In addition to the abnormalities in developing midbrain,
we also noted a complete loss of Pitx2 mRNA expression in
the e14.5 Pitx2/ subthalamic nucleus (n = 5) (Figs. 4A–Fig. 3. PITX2 is required for superior colliculus rostral projections. In the sup
retrogradely labeled neurons are observed in the mantle layer after diI injection in th
retrogradely labeled cells in similar tectal domains in parallel staining experiments (
meso-diencephalic limit and the orientation of the section plane. The ventricle (v) is
obtained in wild-type and Pitx2/ brains. Abbreviations: PT, pretectum; OT, optiD). Absence of Pitx2 mRNA expression in the e14.5
Pitx2/ subthalamic nucleus was associated with denser
expression of Pitx2 mRNA in the intermediate and sub-
ventricular zones of the ventrolateral thalamic neuroepithe-
lium (Figs. 4A, B), raising the possibility that Pitx2 mutant
subthalamic nucleus neurons adopt a more medial fate. We
also observed absence of Pitx2 mRNA in the differentiating
zone of the e13.5 Pitx2/ ventrolateral thalamic neuro-
epithelium with accumulation of Pitx2 mRNA near the
ventricle (Figs. 4E, F). Pitx2 mRNA expression patterns
were similar in the ventrolateral thalamus of e12.5 and
earlier wild-type and Pitx2/ embryos, suggesting a stage-
specific effect of Pitx2 loss of function (data not shown).
Technically, the increased Pitx2 mRNA in the subventric-
ular and marginal zones of the thalamic neuroepithelium in
e13.5–14.5 Pitx2/ embryos may indicate increased Pitx2
mRNA per cell, or reduced Pitx2 mRNA degradation in the
Pitx2/ embryo. Alternatively, increased Pitx2 expression
in cells near the ventricle in the ventrolateral thalamus of
Pitx2/ embryos may represent an arrest of lateral migra-
tion in these cells or accumulation of neural precursors,
mimicking the midbrain defects described above. Our
experiments indicate that Pitx2 is required for initiating
normal neuronal differentiation in the ventrolateral thalamic
neuroepithelium and midbrain, but other regions expressing
Pitx2 appear to be unaffected at early stages.
PITX2 specifies subthalamic nucleus neurons and is
required for their development
To better define the origin and identity of subthalamic
nucleus neurons, we analyzed PITX2 expression in the
midgestation subthalamic nucleus (Figs. 5B, C) and identi-
fied colocalization with markers of terminally differentiated
neurons (Figs. 5D–F, J–L). PITX2 protein localizes duringerior colliculus mantle layer of e13.5 control wild-type embryos (A–C),
e meso-diencephalic junction. In e13.5 Pitx2/ brains, there were far fewer
D–F). The drawing in the upper right represents the site of diI insertion in the
the developing cerebral aqueduct. The lower drawing schematizes the results
c tectum; v, cerebral aqueduct; STN, subthalamic nucleus.
Fig. 4. PITX2 is required for subthalamic nucleus development. In situ
hybridization with a Pitx2 antisense probe (A–F) and immunohistochem-
istry with anti-calretinin (G–J), on coronal sections from wild-type
embryos, reveals Pitx2 and calretinin expression in the subthalamic
nucleus (hatched ellipses in C, E, I) with bilateral loss of Pitx2 and
calretinin in the Pitx2/ ventrolateral thalamus (hatched ellipses in D, F,
J). All sections are oriented as shown in the vertical line in Fig. 5A. Boxes
in A, B, G, and H are enlarged in C, D, I, and J, respectively. Pitx2 in situ
hybridization at e13.5 (E, F) indicates loss of Pitx2 mRNA in the lateral-
most aspect of the Pitx2/ ventral thalamus with denser signal (brackets)
nearer the ventricle. Scale bars are 500 Am (A, B, G, H), 100 Am (E, F),
and 50 Am (C, D, I, J).
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the developing thalamus, including the subthalamic nucleus
(Martin et al., 2002), an almond-shaped structure that
occupies the lateral wall of the rodent ventral thalamus
(Altman and Bayer, 1986; Marchand, 1987). PITX2-posi-
tive neurons comprise the majority of cells in the e14.5
subthalamic nucleus, as revealed by co-labeling of anti-
bodies against PITX2 and NeuN (a nuclear marker
expressed in developing neurons), calretinin (a calcium
binding protein), or the nuclear stain DAPI (Figs. 5D–L).
The e14.5 mouse subthalamic nucleus spans 420–450 Am
in rostro-caudal dimension and expresses prominent levels
of calretinin as indicated by anti-calretinin immunolabeling
(Figs. 5J–L). Our immunohistochemical studies indicate
that the majority of e14.5 mouse subthalamic nucleus
neurons expresses PITX2 and calretinin.
In rat, neurons of the subthalamic nucleus exit the cell
cycle at e12.5–e15.5 in the medial mammillary recess and
migrate dorsoventrally to occupy the e14.5–e17.5 subtha-
lamic nucleus (Altman and Bayer, 1986; Marchand, 1987).
To determine when subthalamic nucleus neurons are born in
the mouse, we performed birthdating experiments using
BrdU, a nucleoside analog incorporated into DNA during
S phase (Gratzner et al., 1976). We injected BrdU into the
peritoneum of pregnant dams at e12.5 and harvested em-
bryos at e14.5 for immunohistochemistry. Using this ap-
proach, we detected colocalization of BrdU and PITX2 in
the e14.5 subthalamic nucleus of normal mice (Figs. 5M–
O), indicating that a significant fraction of cells in the
subthalamic nucleus typically leave the cell cycle around
e12.5 and migrate to their final destinations by e14.5. Not
all e14.5 PITX2-positive subthalamic nucleus neurons are
BrdU-positive after a single e12.5 BrdU injection, suggest-
ing that some subthalamic nucleus neurons are born before
e12.5. This is consistent with prior rat studies showing birth
of subthalamic nucleus neurons at e12.5–15.5, which cor-
responds to e10.5–14.5 in the mouse.
Overall brain morphology was grossly undisturbed in
Pitx2/ embryos at e14.5 (Figs. 1C, D). Since the sub-
thalamic nucleus is difficult to identify in e14.5 embryos (it
becomes histologically distinct at e15–e16), it is possible
that neurons normally destined to form the e14.5 Pitx2/
subthalamic nucleus are either missing or abnormally dif-
ferentiated. To address this, we analyzed several markers of
mature and embryonic subthalamic nucleus in Pitx2/
embryos. Immunolabeling with anti-calretinin in multiple
sections through four embryos and every section of one
embryo revealed absence of calretinin expression through-
out the Pitx2/ thalamic region expected to contain the
subthalamic nucleus (Figs. 4G–J), indicating that loss of
Pitx2 also disrupts calretinin expression in the subthalamic
nucleus. There were no differences between e14.5 wild-type
and Pitx2/ embryos in the distribution of Gad1 mRNA,
GABA immunoreactivity, tyrosine hydroxylase immunore-
activity, or immunoreactivity for R-cadherin (Redies et al.,
2000) (data not shown), indicating that Pitx2 function is not
Fig. 5. PITX2-positive neurons comprise the subthalamic nucleus and are born at e12.5. Panel A illustrates, in sagittal view, the plane of coronal e14.5 sections
for all other panels, with anterior to the left. In situ hybridization with a Pitx2 antisense mRNA probe (B, C) and fluorescent double-label
immunohistochemistry (D–O) with antibodies against PITX2 and NeuN (D–F), DAPI (G–I), calretinin (J–L), or BrdU (M–O). Pitx2 mRNA and protein
occupy the NeuN- and Calretinin-positive subthalamic nucleus. The box inserted in panel B is enlarged in C and also corresponds to the area shown in panels
D–O. Images F, I, L, and O are merged from the two images to their left. In panels M–O, sections were taken from embryos exposed to BrdU at e12.5, and
harvested at e14.5. Scale bars are 200 Am (B), 50 Am (C), 25 Am (D–L), and 10 Am (M–O).
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gic lineages.
Given the loss of both Pitx2 and calretinin gene expres-
sion in the subthalamic nucleus of Pitx2/ mutant embryos
(Fig. 4), we hypothesized a role for PITX2 in development
of subthalamic nucleus neurons or their axonal projections.
Using retrograde axonal tracing experiments, we analyzed
subthalamic–mesencephalic projections, which connect
subthalamic cells with substantia nigra and other tegmental
nuclei in the developing embryo. Projections from subtha-
lamic nucleus to tegmentum were absent in four of five
e13.5 Pitx2/ mice examined (Fig. 6). In one section of
one embryo (Fig. 6J), we identified some retrograde label in
the medial ventrolateral thalamus, which may represent an
ectopically placed STN neuron that has developed a caudal
projection. Together, these results indicate that neurons in
the Pitx2/ ventrolateral neuroepithelium fail to develop
appropriate subthalamic connections with the tegmentum.
This observation also excludes the existence of ectopic
subthalamic neurons at other diencephalic tegmental levels.
Collectively, our observations indicate that embryonic
effects of loss of Pitx2 function in the CNS are region
specific. Neurons of some developing CNS areas, like
ventrolateral thalamus and the mesencephalon, require Pitx2
for normal neuronal differentiation and axonal outgrowth,
whereas other regions, like zona limitans, appear to develop
normal gene expression in the absence of Pitx2.
In late gestation (e14.5–e18.5), the normal mouse sub-
thalamic nucleus undergoes cellular expansion and morpho-
logical changes, making the subthalamic nucleus easier to
distinguish in histological sections. Given the dosage-sensi-
tive effects of Pitx2 in other tissues, we predicted thatFig. 6. PITX2 is required for subthalamo-tegmental projections. In the subthalam
observed after diI injection in the meso-diencephalic junction (B–C). Similar ret
brains, no retrogradely labeled cells in the subthalamic nucleus were present (G–J
medial ventrolateral thalamus. Panel K is a schematic representation of diI insertio
the subthalamic nucleus region in sections labeled with Hoechst dye. Abbreviati
nucleus.subthalamic nucleus may also be affected by reduced Pitx2
function as present in the hypomorphic Pitx2neo allele. To
address this possibility, we analyzed subthalamic nucleus
gene expression in e16.5 Pitx2neo/ and e18.5 Pitx2neo/neo
embryos. We found preservation of Pitx2 mRNA and calre-
tinin immunohistochemistry in the subthalamic nucleus of
e16.5 Pitx2neo/ and e18.5 Pitx2neo/neo embryos (data not
shown). Since these experiments do not rule out the possi-
bility of delayed subthalamic nucleus development with hy-
pomorphic Pitx2 function, we assayed Pitx2 mRNA in the
e14.5 subthalamic nucleus of Pitx2+/+, Pitx2+/, Pitx2/,
Pitx2neo/, and Pitx2neo/neo embryos. We found consistent
subthalamic nucleus Pitx2 mRNA in all genotyped embryos
except Pitx2/ (compare Figs. 4C and D with Fig. 7),
suggesting that a minimal level of Pitx2 function such as that
present in Pitx2neo/ embryos is sufficient for normal sub-
thalamic nucleus formation, whereas complete absence of
Pitx2 is not.
Pitx2 deficiency does not disrupt neural precursor
proliferation or birthdating
Failed development of the subthalamic nucleus and
aberrant axonal projections in Pitx2/ embryos led us to
ask whether Pitx2 is also required for neural progenitors to
exit the cell cycle, differentiate into neurons, and migrate
laterally to their final destinations in the ventrolateral
thalamus. To address whether Pitx2 is required for migration
of all neurons in the ventrolateral thalamus, we exposed
Pitx2/ embryos to BrdU by maternal injections at e12.5 or
daily from e10.5 to 13.5, and harvested embryos at e14.5 for
immunohistochemistry. In these experiments, we foundic nucleus of e13.5 wild-type embryos, retrogradely labeled neurons were
rograde labeling was obtained in Pitx2+/ brains (D–E). In e13.5 Pitx2/
). G– I are from the same embryo. J shows a retrogradely labeled cell in the
n and the orientation of the section plane. Yellow arrows in A and F point to
ons: cp, cerebral peduncle; mt, mammillothalamic tract; STN, subthalamic
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thalamus, from the ventricular zone to the lateral differen-
tiating zone, in both wild-type and Pitx2/ embryos (data
not shown). We also found a normal distribution of immu-noreactivity for NeuN and Nestin, markers of neural pro-
genitors, in the Pitx2/ e14.5 neuroepithelium (data not
shown). These observations suggest that neurons in the
ventrolateral thalamus do not require Pitx2 to exit the cell
cycle and begin their lateral migration in the neuroepithe-
lium, but without Pitx2, they are unable to complete this
migration and form subsequent axonal projections.
Accumulation of Pitx2-positive label in the medial ven-
tral thalamus of Pitx2/ embryos (Fig. 4) could indicate an
increase in the number of neural precursor cells, accumula-
tion of aberrant Pitx2 mRNA, or an inability of existing cells
to exit the cell cycle. To examine for these possibilities, we
performed immunohistochemistry in the e14.5 wild-type
and Pitx2/ ventrolateral thalamus using cell phase-specif-
ic markers to label G1 phase (cyclin D2), S phase (30-min
pulse BrdU), or M phase (phosphohistone H3). These
experiments were performed on sections containing the
subthalamic nucleus region of ventrolateral thalamus (Figs.
8A, B). We found no differences in the distribution of these
three markers in e14.5 Pitx2/ embryos as compared to
their wild-type littermates (Figs. 8C–H), suggesting that
Pitx2-expressing cells in the ventral thalamus are not
mitotically active and are unlikely to represent neural
progenitor cells.
Neuronal apoptosis during regional specialization of the
CNS neuroepithelium results in a diminution in the ultimate
number of neurons that survive to form the adult brain (Roth
and D’Sa, 2001). To determine whether increased cell death
contributes to failed subthalamic nucleus development, we
performed TUNEL assays on multiple sections through the
ventrolateral thalamus from three e14.5 Pitx2/ and wild-
type littermate embryo pairs. We detected no differences in
the extent or site of apoptotic cells between Pitx2/ and
wild-type sections (data not shown), suggesting that Pitx2 is
not necessary for regulating the normal apoptotic program
in the subthalamic nucleus region. Based on our data, Pitx2
is not essential for signaling mitotically active cells to exit
the cell cycle; rather, it appears to be involved in postmitotic
regulation of CNS neuronal differentiation by influencing
migration and axonal outgrowth.
PITX2 is not required for early formation of other basal
ganglia nuclei
The subthalamic nucleus serves as a relay station be-
tween other basal ganglia nuclei. Striatal inputs to substantia
nigra and globus pallidus occur via direct neuronal projec-Fig. 7. Reduced Pitx2 dosage is permissive for subthalamic nucleus
development. Pitx2 in situ hybridization in e14.5 embryos with varying
levels of Pitx2 function. Intact subthalamic nucleus development is present in
all embryos with varying levels of Pitx2 function, including normal (A,
Pitx2+/+), heterozygous null (B, Pitx2+/), homozygous hypomorphic (C,
Pitx2neo/neo), and hypomorphic null (D, Pitx2neo/). Hatched ellipses indicate
the subthalamic nucleus region in the ventrolateral neuroepithelium. In each
panel, the plane of section is represented by the line in Fig. 5A, with lateral to
the left and dorsal up. Scale bars are 100 Am.
Fig. 8. Pitx2 deficiency does not disrupt expression of cell cycle markers in the ventrolateral thalamus. Pitx2 mRNA (A, B) is present in e14.5 wild-type
ventrolateral thalamus and absent in Pitx2/ sections. In adjacent sections, arranged from rostral to caudal, there is unchanged immunoreactivity for H3 (C,
D), BrdU (E, F), and cyclin D2 (G, H) in Pitx2/ embryos as compared to wild-type littermates. Sections in C–H are merged images of TRITC or Alexa 555-
labeled H3, BrdU, or cyclin D2 immunoreactivity (pink), counterstained with DAPI (blue). Plane of section is shown by the line in Fig. 5A, with lateral to the
left and dorsal up. Scale bars are 100 Am.
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subthalamic nucleus (Smith and Kieval, 2000). In the adult
human and rat, where many of these studies have been
performed, subthalamic nucleus neurons receive projectionsfrom cortex, striatum, globus pallidus, and substantia nigra,
and send axonal projections to globus pallidus, substantia
nigra, and tegmental pedunculo-pontine nucleus (Parent and
Hazrati, 1995). None of these other basal ganglia regions
D.M. Martin et al. / Developmental Biology 267 (2004) 93–108104express Pitx2; however, we hypothesized that selective
disruption of the subthalamic nucleus in Pitx2/ embryos
may influence trophic effects of subthalamic nucleus neu-
rons on formation of other basal ganglia nuclei.
We analyzed multiple sections of e14.5–18.5 Pitx2-defi-
cient embryos by cresyl violet staining, and found no histo-
logical abnormalities in other CNS tegmental and basal
ganglia nuclei. In the striatum and globus pallidus, Gad1
mRNA and GABA immunoreactivity were normal in e14.5
Pitx2/ embryos (Figs. 9A, B and data not shown), suggest-Fig. 9. Formation of other basal ganglia neurons is PITX2-independent. In
situ hybridization for Gad1 on e14.5 coronal wild-type (A) and Pitx2/ (B)
sections reveals unchanged Gad1 mRNA in Pitx2/ embryos, with intact
label in globus pallidus (GP). Immunohistochemistry with anti-TH (C, D)
shows preservation of substantia nigra compacta (SNc) and the nigrostriatal
pathway (nsp) in e14.5 Pitx2/ embryos. Enkephalin mRNA is expressed
in striatal cells (straight lines) of e14.5 wild-type (E) and Pitx2/(F)
embryos by in situ hybridization. Striatal (STR) substance P (Sub P) mRNA
expression is similar in wild-type (G) and Pitx2/ embryos (H). Scale bars
are 500 Am (A, B), 100 Am (C, D, G, H), and 50 Am (E, F).ing that the initial establishment of GABAergic neurons in
these regions is not Pitx2-dependent. The substantia nigra, a
target of subthalamic nucleus neuronal axons, contains
GABAergic neurons and dopaminergic, tyrosine hydroxy-
lase-expressing neurons with reciprocal connections to sub-
thalamic nucleus (Smith and Kieval, 2000). We identified
normal GABAergic immunoreactivity (data not shown) and
tyrosine hydroxylase immunoreactivity throughout wild-type
and Pitx2/ mutant e14.5 substantia nigra and nigrostriatal
pathway (Figs. 9C, D), providing evidence that initial forma-
tion of nigral and nigrostriatal neurons is not dependent on
Pitx2 or normal subthalamic nucleus development.
To determine whether the direct or indirect striatopallidal
pathways are affected by loss of Pitx2, we assessed sub-
stance P and enkephalin mRNA, respectively, in the devel-
oping striatum. Both substance P and enkephalin mRNA
were expressed normally in the e14.5 Pitx2/ striatum
(Figs. 9E–H), suggesting that Pitx2-mediated disruption of
subthalamic nucleus development does not adversely affect
initial formation of striatal direct and indirect pathway
neurons. Together with normal Gad1/GABA and TH ex-
pression, it appears that absence of Pitx2 and failure of
subthalamic nucleus formation do not adversely affect initial
formation of other tegmental motor and basal ganglia
regions, and that loss of Pitx2 does not promote a cell fate
switch permitting neurons to adopt a GABAergic or dopa-
minergic fate. Pitx2 is expressed in the mature rodent
subthalamic nucleus (Mucchielli et al., 1996); however,
the early lethality of Pitx2-deficient mice precludes analysis
of Pitx2 involvement at later times during development and
in the establishment or maintenance of adult subthalamic
nucleus and basal ganglia function.Discussion
In this study, we found that Pitx2 loss of function results
in a region-specific disruption of neuronal differentiation
and axonal outgrowth. PITX2 protein is necessary for
normal development of the subthalamic nucleus and its
projections to the tegmentum, as well as for projections
arising in the midbrain. We observed no Pitx2 dependence
in the early development of other basal ganglia regions,
suggesting that the developmental requirement for Pitx2
within the basal ganglia is specific to the subthalamic
nucleus. We also identified no changes in the ability of
mitotic cells in the ventrolateral thalamus to exit the cell
cycle, initiate lateral migration, and differentiate into neu-
rons. We saw no differences between Pitx2 mutant and wild-
type brains in expression of markers of neural progenitors
(Nestin, NeuN), differentiated neurons (TuJ1, Map2), or
GABAergic neurotransmitter phenotype. Absence of calre-
tinin and abnormalities in axonal projections in the sub-
thalamic nucleus with Pitx2 mutations provide evidence that
Pitx2 is required to establish functional connectivity of these
terminally differentiated neurons. These observations indi-
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ment for Pitx2 in neuronal development.
Our studies suggest that the requirement of Pitx2 for
subthalamic nuclear formation applies only to highly spe-
cific subsets of neurons within the neuroepithelium. This
contrasts with Pitx2 function in the eye, where mesenchy-
mal Pitx2 expression influences development of the optic
nerve and other ocular structures (Gage et al., 1999). Our
data represent the first report of a phenotypic CNS abnor-
mality associated with Pitx2 deficiency, and the only known
genetic requirement for subthalamic nucleus formation.
In the dorsal mesencephalon or future superior colliculus,
Pitx2 expression is required for normal early neuronal
differentiation, that at the analyzed stages, corresponds with
radial movement of tectal projection cells (Tan et al., 2002).
The normal mouse superior colliculus develops as a laminar
structure, with intense neurogenesis proceeding from e11 to
e15 (Edwards et al., 1986). The ectopic localization of Pitx2
expressing cells in the subventricular zone of Pitx2 mutant
mesencephalon, together with the normal development of
GABAergic neurons, suggests that Pitx2 specifies identity
of specific layers of neurons in the developing superior
colliculus. Pitx2-dependent neuronal differentiation appears
to include normal axonal outgrowth and the development of
tectal projections towards anterior brain structures.
Comparison to Pitx2 effects in other tissues and organisms
Pitx2-dependent neuronal development in the subthala-
mic nucleus and mesencephalon is consistent with its
dosage-sensitive role in the initial expansion and subsequent
differentiation of pituitary cell types (Gage et al., 1999; Suh
et al., 2002). Pituitary hypoplasia in Pitx2/ embryos is
associated with a marked reduction in cellular proliferation
(Kioussi et al., 2002) and an increase in cell death (Suh,
personal communication). We detected no changes in cel-
lular proliferation or birthdating in the Pitx2 mutant ventro-
lateral thalamus. Although subtle changes are difficult to
exclude, our data suggest that Pitx2 effects on cell cycle
may be highly tissue specific. Pitx2 appears necessary for
developing neurons to receive or respond to signals that
promote their terminal differentiation, possibly via effects
on migration, aggregation, and axonal outgrowth as they
reach the ventrolateral wall of the thalamus and the pial
surface of the mesencephalon.
Analysis of Pitx2 and Pitx2-related genes in other organ-
isms has yielded some information about a potential role in
developing neurons. In Caenorhabditis elegans, the Pitx2-
related gene unc-30 is essential for normal formation and
axonal outgrowth of GABAergic neurons (Westmoreland et
al., 2001). This contrasts with our results showing intact
Gad1/GABA expression in Pitx2/ embryos. In zebrafish,
Pitx2 participates in establishment of left–right asymmetry
in the developing embryo, and Pitx2 expression occupies
the future habenular nucleus of the diencephalon, which,
along with the pineal gland, exhibits left–right asymmetricdevelopment (Piedra et al., 1998; Ryan et al., 1998; Yosh-
ioka et al., 1998). We detected no PITX2 expression in the
embryonic mouse habenular nucleus or the pineal gland,
and these structures appeared normal in Pitx2/ embryos
(data not shown). In addition, we observed neither asym-
metries in Pitx2 expression in any CNS regions, nor any
left–right differences in subthalamic nucleus development
in wild-type or Pitx2/ embryos. Phenotypic differences in
Pitx2 function across species suggest evolutionary diver-
gence that may partly explain why CNS defects associated
with loss of PITX2 in humans are not present in mice.
Transcriptional targets of PITX2 in the subthalamic nucleus
The downstream targets of PITX2 transcriptional activa-
tion or repression in the brain are not known. It is intriguing
that the mouse calretinin promoter contains a bicoid binding
site that matches the PITX2 consensus sequence (Quentien et
al., 2002; Strauss et al., 1997). However, many CNS regions
expressing calretinin (Martinez and Puelles, 2000) are neg-
ative for PITX2, excluding a ubiquitous requirement of
PITX2 binding for normal calretinin gene expression. In
the pituitary, PITX2 activates lineage-specific transcription
factors that are necessary for terminal differentiation of
hormone-producing cells (Suh et al., 2002). Pitx2 may
perform a similar function in the subthalamic nucleus, or it
may be the equivalent of a lineage specific transcription
factor functioning collaboratively with more broadly
expressed transcription factors to specify the subthalamic
nucleus.
Subthalamic nucleus contributions to basal ganglia
pathways
Our data have implications for the pathophysiology of
movement disorders. In animals and humans, unilateral
lesions of the subthalamic nucleus cause abnormal limb
movements on the side contralateral to the lesion (Albin et
al., 1989). In the hypokinetic disorder Parkinson’s disease,
increased neuronal activity in the subthalamic nucleus can be
ameliorated with electrical stimulation, which is clinically
useful in patients who develop refractoriness to dopamine
agonists (Tintner and Jankovic, 2002). Current models of
basal ganglia function suggest two different routes of infor-
mation flow from striatum to globus pallidus and subsequent-
ly to thalamic output nuclei (Albin et al., 1989) (Fig. 10). The
subthalamic nucleus participates in the indirect pathway of
basal ganglia circuitry, wherein striatal neurons project onto
medial or internal globus pallidus neurons, which themselves
project to subthalamic nucleus. GABAergic striatal neurons
expressing enkephalin initiate this indirect pathway, whereas
substance P-expressing GABAergic striatal neurons project
to lateral or external globus pallidus, and its neurons project
directly to the thalamus.
Reiner et al. have detected the direct and indirect path-
ways both in birds (Jiao et al., 2000) and mammals (Reiner
Fig. 10. Model of Pitx gene function in basal ganglia connectivity. Pitx2 is expressed in the subthalamic nucleus (STN) and is essential for projections to the
tegmentum, an area containing future substantia nigra reticulata (SNr). These projections are predicted to be glutamatergic (Glu). Pitx3 maintains substantia
nigra compacta (SNc) dopaminergic (DA) neurons that project to the striatum. GABAergic direct pathway projections go from striatum to globus pallidus
interna (GPi) and express substance P. GABAergic indirect pathway projections go from striatum to globus pallidus externa (GPe), express enkephalin, and
synapse first in the STN. This model is adapted from the original (Albin et al., 1989).
D.M. Martin et al. / Developmental Biology 267 (2004) 93–108106et al., 1998). There are also sparse projections in the rat from
the subthalamic nucleus to substance P and enkephalin-
expressing striatal neurons (Kita and Kitai, 1987). Our
findings that Gad1, substance P, and enkephalin mRNA
are normally expressed in the striatum of Pitx2 mutant
embryos indicate that initial establishment of striatal neu-
rons forming the direct and indirect pathways is unaffected
by loss of Pitx2. Similar results were observed in a mouse
model of Huntington disease, where heterozygous deletions
in exon 5 of Hdh, the mouse homologue of the human
Huntington gene, are associated with a 51% loss of sub-
thalamic nucleus neurons and intact enkephalin and sub-
stance P expression (O’Kusky et al., 1999).
Our results also suggest a requirement of Pitx2 for
subthalamo-substantia nigra glutamatergic projections.
These glutamatergic projections likely transmit excitatory
signals from the subthalamic nucleus to substantia nigra
neurons, and exhibit hyperexcitation in late stages of Par-
kinson’s disease, based on evidence in rats and monkeys,
where pharmacological lesion of substantia nigra neurons
induces an increase in Gad1 mRNA that is reversed by high-
frequency subthalamic nucleus stimulation or kainic acid-
induced subthalamotomy (Guridi et al., 1996; Salin et al.,
2002). In contrast to the loss of subthalamo-mesencephalic
projections, we found no changes in tyrosine hydroxylase
immunoreactivity throughout the developing Pitx2/ sub-
stantia nigra or nigrostriatal pathway, indicating that early
loss of the subthalamic nucleus does not alter the initial
formation of nigral neurons or their projections. It is not yet
known whether loss of substantia nigra adversely influences
subthalamic nucleus development, or if later effects of
genetically induced lesions in the subthalamic nucleus cause
neurodegeneration in subthalamic nuclear targets.
Pitx2 mRNA expression persists in wild-type postnatal
mouse and rat subthalamic nucleus (Mucchielli et al., 1996;
Smidt et al., 2000), and may be involved in maintenance ofaxonal projections, neuronal survival, or in some other as
yet unidentified function. The requirements of subthalamic
nucleus and midbrain for Pitx2 during development raise the
possibility that Pitx2 is necessary for maintenance of neu-
ronal function or connectivity in the adult. Conditional gene
targeting approaches are likely to prove informative in
genetically dissecting subthalamic nucleus and mesence-
phalic function in mature mice, and may provide useful
animal models in which to analyze the roles of basal ganglia
connectivity in development and disease.Acknowledgments
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